市場調查報告書
商品編碼
1029310

腦膜炎疫苗的全球市場:產業趨勢,佔有率,規模,成長,機會,預測(2021年-2026年)

Meningococcal Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 148 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球腦膜炎疫苗市場規模,2020年達到28億美元的規模,預計從2021年到2026年以9.5%的年複合成長率成長。

促進市場成長的重要要素,是腦膜炎感染疾病,在全球幼兒和青少年之間流行,國民的健康意識高漲與定期性的疫苗接種的引進。腦膜炎疫苗預防此病,一時性或持續性抑制聽障,視力和運動能力降低,痙攣,神經病變等長期性的影響。

本報告提供全球腦膜炎疫苗市場相關調查分析,全球市場,各疫苗,各組成類別,各疫苗血清型,各流通管道,各終端用戶,各地區市場市場區隔,SWOT分析,價值鏈分析,波特五力分析,價格分析,競爭情形,企業簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球腦膜炎疫苗市場

  • 市場概要
  • 市場效能
  • COVID-19的影響

第6章 市場區隔:各疫苗類型

  • 有效利用
  • 多糖類
  • 被覆下

第7章市場區隔: 各組成類別

  • 東西疫苗
  • 混合疫苗

第8章 市場區隔:各疫苗血清型

  • MenACWY
  • MenB&manikku
  • MenC
  • MenA
  • MenAC
  • 其他

第9章 市場區隔:各流通管道

  • 醫院藥局
  • 零售藥局
  • 機構投資者銷售
  • 其他

第10章 市場區隔:各終端用戶

  • 兒童
  • 大人

第11章 市場區隔:各地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔:各國

第12章 SWOT分析

第13章 價值鏈分析

第14章 波特五力分析

第15章 價格分析

第16章 競爭情形

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • GlaxoSmithKline Plc
    • Hualan Biological Engineering Inc.
    • Incepta Pharmaceuticals Limited
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Serum Institute of India Ltd.
    • Walvax Biotechnology Co. Ltd.
目錄
Product Code: SR1020F260_Report

The global meningococcal vaccines market reached a value of US$ 2.8 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future.

The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global meningococcal vaccines market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on vaccine type, composition, vaccine serotype, distribution channel and end user.

Breakup by Vaccine Type:

  • Conjugate
  • Polysaccharide
  • Subcapsular

Breakup by Composition:

  • Mono Vaccines
  • Combination Vaccines

Breakup by Vaccine Serotype:

  • MenACWY
  • MenB & Manic
  • MenC
  • MenA
  • MenAC
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Sales
  • Others

Breakup by End User:

  • Pediatric
  • Adult

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd. Key Questions Answered in This Report:

  • How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global meningococcal vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the composition?
  • What is the breakup of the market based on the vaccine serotype?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global meningococcal vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Meningococcal Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Conjugate
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Polysaccharide
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Subcapsular
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Composition

  • 7.1 Mono Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Combination Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Vaccine Serotype

  • 8.1 MenACWY
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 MenB & Manic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 MenC
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 MenA
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 MenAC
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Institutional Sales
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pediatric
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Adult
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 GlaxoSmithKline Plc
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Hualan Biological Engineering Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Incepta Pharmaceuticals Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Novartis AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Pfizer Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Sanofi S.A.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Serum Institute of India Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Walvax Biotechnology Co. Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials

List of Figures

  • Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2020
  • Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2020
  • Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2020
  • Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2020
  • Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2020
  • Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2020
  • Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
  • Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
  • Figure 94: Global: Meningococcal Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2021-2026
  • Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million US$), 2021-2026
  • Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million US$), 2021-2026
  • Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
  • Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
  • Table 9: Global: Meningococcal Vaccines Market: Key Players